BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23640463)

  • 1. Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts.
    Huang SK; Scruggs AM; Donaghy J; Horowitz JC; Zaslona Z; Przybranowski S; White ES; Peters-Golden M
    Cell Death Dis; 2013 May; 4(5):e621. PubMed ID: 23640463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.
    Sanders YY; Hagood JS; Liu H; Zhang W; Ambalavanan N; Thannickal VJ
    Eur Respir J; 2014 May; 43(5):1448-58. PubMed ID: 24603818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dynamic changes in histone acetylation and deacetylase activity on pulmonary fibrosis.
    Li M; Zheng Y; Yuan H; Liu Y; Wen X
    Int Immunopharmacol; 2017 Nov; 52():272-280. PubMed ID: 28961490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts.
    Zhang X; Liu H; Hock T; Thannickal VJ; Sanders YY
    Int J Mol Sci; 2013 Sep; 14(10):19605-17. PubMed ID: 24084714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
    Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
    Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.
    Bamberg A; Redente EF; Groshong SD; Tuder RM; Cool CD; Keith RC; Edelman BL; Black BP; Cosgrove GP; Wynes MW; Curran-Everett D; De Langhe S; Ortiz LA; Thorburn A; Riches DWH
    Am J Respir Crit Care Med; 2018 Oct; 198(7):914-927. PubMed ID: 29727583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
    PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Regulation of Caveolin-1 Gene Expression in Lung Fibroblasts.
    Sanders YY; Liu H; Scruggs AM; Duncan SR; Huang SK; Thannickal VJ
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):50-61. PubMed ID: 27560128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis.
    Redente EF; Chakraborty S; Sajuthi S; Black BP; Edelman BL; Seibold MA; Riches DW
    JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts.
    Sanders YY; Tollefsbol TO; Varisco BM; Hagood JS
    Am J Respir Cell Mol Biol; 2011 Jul; 45(1):16-23. PubMed ID: 20724553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of H4K16Ac levels reduces pro-fibrotic gene expression and mitigates lung fibrosis in aged mice.
    Zhang X; Liu H; Zhou JQ; Krick S; Barnes JW; Thannickal VJ; Sanders YY
    Theranostics; 2022; 12(2):530-541. PubMed ID: 34976199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis.
    Coward WR; Watts K; Feghali-Bostwick CA; Knox A; Pang L
    Mol Cell Biol; 2009 Aug; 29(15):4325-39. PubMed ID: 19487460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis.
    Conforti F; Davies ER; Calderwood CJ; Thatcher TH; Jones MG; Smart DE; Mahajan S; Alzetani A; Havelock T; Maher TM; Molyneaux PL; Thorley AJ; Tetley TD; Warner JA; Packham G; Ganesan A; Skipp PJ; Marshall BJ; Richeldi L; Sime PJ; O'Reilly KMA; Davies DE
    Oncotarget; 2017 Jul; 8(30):48737-48754. PubMed ID: 28467787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of EC-SOD expression in aging lung fibroblasts: Role of histone acetylation.
    Roman J; Zhu J; Ritzenthaler JD; Zelko IN
    Free Radic Biol Med; 2017 Nov; 112():212-223. PubMed ID: 28757400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.
    Korfei M; Mahavadi P; Guenther A
    Cells; 2022 May; 11(10):. PubMed ID: 35626663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase and telomere length in pulmonary fibrosis.
    Liu T; Ullenbruch M; Young Choi Y; Yu H; Ding L; Xaubet A; Pereda J; Feghali-Bostwick CA; Bitterman PB; Henke CA; Pardo A; Selman M; Phan SH
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):260-8. PubMed ID: 23526226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-29c regulates apoptosis sensitivity via modulation of the cell-surface death receptor, Fas, in lung fibroblasts.
    Matsushima S; Ishiyama J
    Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1050-L1061. PubMed ID: 27765762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of fibroblast Fas expression by soluble and mechanical pro-fibrotic stimuli.
    Dodi AE; Ajayi IO; Chang C; Beard M; Ashley SL; Huang SK; Thannickal VJ; Tschumperlin DJ; Sisson TH; Horowitz JC
    Respir Res; 2018 May; 19(1):91. PubMed ID: 29747634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.
    Korfei M; Skwarna S; Henneke I; MacKenzie B; Klymenko O; Saito S; Ruppert C; von der Beck D; Mahavadi P; Klepetko W; Bellusci S; Crestani B; Pullamsetti SS; Fink L; Seeger W; Krämer OH; Guenther A
    Thorax; 2015 Nov; 70(11):1022-32. PubMed ID: 26359372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis.
    Coward WR; Watts K; Feghali-Bostwick CA; Jenkins G; Pang L
    Mol Cell Biol; 2010 Jun; 30(12):2874-86. PubMed ID: 20404089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.